Clinical Trial Update: Sparing of Organs at Risk in High Dose Rate Brachytherapy

View source ↗

Summary

A completed clinical trial evaluating organ-sparing strategies during high-dose-rate brachytherapy for cervical cancer (stages IB–IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Cervical Carcinoma Stage IB to IV | Status: COMPLETED